Table 1.
Patient characteristics.
| Patient No |
Sex | Age | Tumor Type |
Clinical T-Stage |
PA T-Stage |
Fluorescence in Tumor (Y/N) |
TBR | c-Met Status * |
|---|---|---|---|---|---|---|---|---|
| 1 | M | 72 | OSCC | T1 | T1 | Y | 1.8 ± 0.3 | + |
| 2 | M | 62 | OSCC | T3 | T2 | Y | 2.5 ± 0.7 | +/++ |
| 3 | M | 56 | OSCC | T2 | T2 | Y | 2.0 ± 0.1 | +/++ |
| 4 | F | 86 | OSCC | T1 | T1 | Y | 2.5 ± 0.5 | + |
| 5 | F | 80 | OSCC | T2 | T1 | Y | 2.4 ± 0.3 | ++/+++ |
| 6 | F | 67 | OSCC | T2 | T2 | Y | 2.7 ± 0.3 | + |
| 7 | M | 68 | OSCC | T1 | T1 | Y | 3.1 ± 0.7 | +/++ |
| 8 | F | 68 | OSCC | T2 | T2 | Y | 2.3 ± 0.8 | +++ |
| 9 | F | 76 | OSCC | T1 | T1 | N | N.A. | ++ |
| 10 | M | 36 | OSCC | T1 | T1 | Y | 2.5 ± 0.5 | +/++ |
OSCC: oral squamous cell carcinoma. TBR: Tumor-to-background ratio. N.A.: Not available. No tumor detected; therefore, ratio fluorescence signal in tumor and surrounding healthy tissue could not be evaluated. * C-Met status as identified on immunohistochemistry.